go-v.orgdoi

Magnetic Resonance Imaging-Detected Tumor Residue after Intensity-Modulated Radiation Therapy and its Association with Post-Radiation Plasma Epstein-Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma

Jia‐Wei Lv, Guan‐Qun Zhou, Jiaxiang Li, Ling‐Long Tang, Yan‐Ping Mao, Aihua Lin, Jun Ma, Ying Hao Sun · Journal of Cancer · 2017

  • DOI 10.7150/jca.17957
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2017

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2017

Abstract

Purpose: To evaluate the prognostic value of magnetic resonance imaging (MRI)-detected tumor residue after intensity-modulated radiation therapy (IMRT) and its association with post-treatment plasma Epstein-Barr virus deoxyribonucleic acid (EBV DNA) in nasopharyngeal carcinoma (NPC).Methods and materials: A prospective database of patients with histologically-proven NPC was used to retrospectively analyze 664 cases.Pre-and post-treatment MRI scans were independently reviewed by two senior radiologists who were blinded to clinical findings.Factors significantly associated with MRI-detected tumor residue were identified and included in the following multivariate logistic regression model.Residual risk model were established.Receiver operating characteristic (ROC) identify the optimal cut-off risk score for tumor residue.Results: MRI-detected residual tumor at three months after IMRT was associated with poor prognosis.The 5-year survival rates for the non-residual and residual groups were: OS (93.8% vs.

76.6%,P<0.001), PFS (84.7% vs. 67.9%,P=0.006), LRFS (93.4% vs. 80.4%, P=0.002), and DMFS (90.3% vs.

87.9%,P=0.305), respectively.Three-month post-treatment EBV DNA was significantly associated with tumor residue (P<0.001).A residual risk score model was established, consisting of T and N categories and post-treatment EBV DNA.ROC identified 22.74 as the optimal cut-off risk score for tumor residue.High-risk score was independently associated with poor treatment outcomes.Conclusions: MRI-detected tumor residue was an independent adverse prognostic factor in NPC; and significantly associated with three-month post-treatment EBV DNA.As limited resources in some endemic areas prevent patients from undergoing routine post-treatment imaging, our study identifies a selection risk-model, providing a cost-effective reference for the selection of follow-up strategies and clinical decision-making.

Open the resolved locator · 10.7150/jca.17957

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 03:40 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v08p0861.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.